Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2023

YO Boxing session

Off-label molecular-guided treatments are a reasonable approach for refractory advanced solid tumours - Yes

Date

21 Oct 2023

Session

YO Boxing session

Topics

Translational Research;  Molecular Oncology

Tumour Site

Presenters

Barbara Kiesewetter-Wiederkehr

Authors

B. Kiesewetter-Wiederkehr

Author affiliations

  • Dept. Of Medicine I, Clin. Dvision Of Oncology, Universitätskliniken der MedUni Wien - AKH Wien, 1090 - Vienna/AT

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.